Search

Showing "11154" results for ""

Alternative to viral load flops in West African field trial

HAART means that HIV-positive patients much less likely to be hospitalised with flu

Boosted PI regimen achieves fastest fall in HIV viral load in patients diagnosed late

Old TB vaccine can improve immune response to TB in HIV patients

Vaxgen announces second phase III trial failure in its AIDSVAX programme

HIV/malaria coinfection increases morbidity and mother to child HIV transmission

NNRTI-based HAART associated with quicker CD4 cell gains than PI-based therapy

Cheap multivitamin pill increases survival in those with low CD4 counts

How will AZT and nevirapine use for MTCT affect future treatment? Two studies provide clues

Total lymphocyte count predicts risk of death in children

Second English HIV transmission prosecution rings alarm bells

High rates of AIDS and death in first year of life argue for universal ART for kids with HIV

US treatment guidelines updated

Brazil wins 75% discount on new HIV drug

HAART does not fully restore brain impairment due to HIV

Cost of care shown to be primary barrier to adherence in African study

South Africa announces treatment roll out - and begins search for health care workers

No difference in post-liver transplant survival between HAART-treated HIV-positive and HIV-negative

Receive the latest HIV research and conference news

Showing "11154" results for ""

Alternative to viral load flops in West African field trial

HAART means that HIV-positive patients much less likely to be hospitalised with flu

Boosted PI regimen achieves fastest fall in HIV viral load in patients diagnosed late

Old TB vaccine can improve immune response to TB in HIV patients

Vaxgen announces second phase III trial failure in its AIDSVAX programme

HIV/malaria coinfection increases morbidity and mother to child HIV transmission

NNRTI-based HAART associated with quicker CD4 cell gains than PI-based therapy

Cheap multivitamin pill increases survival in those with low CD4 counts

How will AZT and nevirapine use for MTCT affect future treatment? Two studies provide clues

Total lymphocyte count predicts risk of death in children

Second English HIV transmission prosecution rings alarm bells

High rates of AIDS and death in first year of life argue for universal ART for kids with HIV

US treatment guidelines updated

Brazil wins 75% discount on new HIV drug

HAART does not fully restore brain impairment due to HIV

Cost of care shown to be primary barrier to adherence in African study

South Africa announces treatment roll out - and begins search for health care workers

No difference in post-liver transplant survival between HAART-treated HIV-positive and HIV-negative

Receive the latest HIV research and conference news